Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Black Stone Minerals
BSM
$3.09B
| $22.2M | 0.02% |
1,343,157
-348,467
| -21% | -$6.22M |
|
527
AB InBev
BUD
$168B
| $22.1M | 0.02% |
201,690
+75,294
| +60% | +$8.09M |
|
|
MJN
528
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $22.1M | 0.02% |
248,400
+215,400
| +653% | +$17.7M |
|
529
PUT
American Express
AXP
$236B
| $22.1M | 0.02% |
278,800
-423,600
| -60% | -$33.1M |
|
530
CALL
Vale
VALE
$63.6B
| $22M | 0.02% |
2,318,700
-1,374,700
| -37% | -$13.7M |
|
531
PUT
UnitedHealth
UNH
$375B
| $22M | 0.02% |
134,300
+1,900
| +1% | +$311K |
|
|
AET
532
PUT
DELISTED
Aetna Inc
AET
| $22M | 0.02% |
172,500
-818,400
| -83% | -$103M |
|
533
Cencora
COR
$61.7B
| $21.6M | 0.02% |
244,377
+158,341
| +184% | +$13.9M |
|
|
TFCFA
534
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $21.5M | 0.02% |
663,178
+60,706
| +10% | +$1.86M |
|
535
Equity Residential
EQR
$25.4B
| $21.4M | 0.02% |
343,621
-304,747
| -47% | -$19.1M |
|
536
PUT
Pfizer
PFE
$147B
| $21.2M | 0.02% |
654,429
-1,219,899
| -65% | -$38.5M |
|
537
Lam Research
LRCX
$385B
| $21.2M | 0.02% |
1,651,070
-2,310,570
| -58% | -$27.2M |
|
|
GAP
538
The Gap Inc
GAP
$7.4B
| $21.2M | 0.02% |
871,044
-87,162
| -9% | -$2.08M |
|
|
ETP
539
CALL
DELISTED
Energy Transfer Partners L.p.
ETP
| $21.1M | 0.02% |
578,900
+173,100
| +43% | +$6.44M |
|
540
SL Green Realty
SLG
$3.9B
| $21.1M | 0.02% |
204,253
+146,768
| +255% | +$15.5M |
|
541
PUT
iShares Silver Trust
SLV
$29.9B
| $21.1M | 0.02% |
1,220,500
-246,800
| -17% | -$4.09M |
|
542
Fortive
FTV
$18.5B
| $21M | 0.02% |
553,562
+358,599
| +184% | +$12.9M |
|
543
Blackrock
BLK
$176B
| $20.8M | 0.02% |
54,210
+7,095
| +15% | +$2.71M |
|
544
PUT
iShares MSCI Japan ETF
EWJ
$22.5B
| $20.6M | 0.02% |
400,325
-475,125
| -54% | -$24.3M |
|
545
JD.com
JD
$43.9B
| $20.6M | 0.02% |
661,821
+119,943
| +22% | +$3.53M |
|
546
CALL
iShares US Real Estate ETF
IYR
$4.67B
| $20.6M | 0.02% |
261,900
-367,400
| -58% | -$28.7M |
|
547
CALL
Regeneron Pharmaceuticals
REGN
$79.1B
| $20.5M | 0.02% |
53,000
+16,200
| +44% | +$6M |
|
548
CALL
Eaton
ETN
$174B
| $20.5M | 0.02% |
276,700
-36,900
| -12% | -$2.62M |
|
549
Carnival Corporation Ltd
CCL
$40.6B
| $20.5M | 0.02% |
348,001
-41,379
| -11% | -$2.31M |
|
550
PUT
TJX Companies
TJX
$177B
| $20.5M | 0.02% |
518,000
+142,600
| +38% | +$5.5M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.